QbD Approach: A Framework for Integrating Quality into Pharmaceutical Products
Monika Kharb, Kamal Singh Rathore
Journal of Pharmaceutical Research International · pp. 1–11 · Published 17 Feb 2022
10.9734/jpri/2022/v34i12A35854Abstract
Introduction: The traditional development processes use a quality by testing (QbT) approach that needs continuous testing to determine quality. Such processes are fixed, averse to change, and focus only on process reproducibility. This approach does not allow variation in material and process controls. In order to overcome the shortcomings of the traditional process, regulatory bodies have issued guidelines for the industries to improve the understanding of the process and the quality of the product. It aims to shift from traditional process QbT to a scientific approach quality by design (QbD) to assure product quality in the pharmaceutical industry. Methodology: Articles related to QbD published in many search engines such as Scopus, Google Scholar, and PubMed were reviewed. Review Findings: In order to ensure the quality of pharmaceutical products, regulatory bodies have emphasized on the implementation of QbD. For this, various guidelines have been published from time to time. The Indian pharmaceutical industry has started to apply the principles of QbD. Implementation of QbD develops a detailed understanding of the manufacturing process. The design space is achieved by QbD within which the expected quality is achieved even with changes in process parameters. Conclusion: In short, the QbD approach is a great tool for assuring pharmaceutical product quality and better understanding of the manufacturing process. Therefore, it is imperative to have a successful implementation of the QbD approach.
References (21)
- 1 International Journal of Pharmaceutics
- 2 Drug Development and Industrial Pharmacy [DOI]
- 3 Design of experiments (DoE) in pharmaceutical development [DOI]
- 4 The Future of Pharmaceutical Manufacturing Sciences [DOI]
- 5 Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer [DOI]
- 6 A Practical Guide to Needs Assessment [DOI]
- 7 Application of Box–Behnken design and desirability function in the development and optimization of self-nanoemulsifying drug delivery system for enhanced dissolution of ezetimibe [DOI]
- 8 In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
- 9 Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control [DOI]
- 10 Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling [DOI]
- 11 Optimization and Formulation of Fucoxanthin-Loaded Microsphere (F-LM) Using Response Surface Methodology (RSM) and Analysis of Its Fucoxanthin Release Profile [DOI]
- 12 Development of an Innovative Quality by Design (QbD) Based Stability-Indicating HPLC Method and its Validation for Clofazimine from its Bulk and Pharmaceutical Dosage Forms [DOI]
- 13 RP-HPLC Stability Indicating Method Development and Validation of Pseudoephedrine Sulfate and Related Organic Impurities in Tablet Dosage Forms, Robustness by QbD Approach [DOI]
- 14 Preparation and Evaluation of the ZnO NP–Ampicillin/Sulbactam Nanoantibiotic: Optimization of Formulation Variables Using RSM Coupled GA Method and Antibacterial Activities [DOI]
- 15 QUALITY BY DESIGN (QBD): A COMPREHENSIVE UNDERSTANDING OF IMPLEMENTATION AND CHALLENGES IN PHARMACEUTICALS DEVELOPMENT
- 16 A Comprehensive Review on Quality by Design (QbD) in Pharmaceuticals
- 17 Process Understanding: For Scale-Up and Manufacture of Active Ingredients [DOI]
- 18 Optimization of formulation and process variables using central composite design for the production of nevirapine spray dried solid dispersion [DOI]
- 19 Analysis and critical review of ICH Q8, Q9 and Q10 from a generic pharmaceutical industry view point [DOI]
- 20 Short review on Quality by design: A new Era of Pharmaceutical drugdevelopment
- 21 Macedonian Pharmaceutical Bulletin [DOI]
Cited by 8
Rohan Panwar, Anuradha Mishra, Abhisar Sahu · AAPS PharmSciTech · 2026
Gaikwad Shubhangee, Anushree A. Kute, Mohd Usman Mohd Siddique · Journal of Analytical Science & Technology · 2025
Mateusz Przywara, Karolina Maria Leś, Marta Piwódzka · Farmacja Polska · 2024
Yogesh Subhash Chaudhari, Manisha Yogesh Chaudhari, Abhijeet Vishnu Puri · Preprints.org · 2024
Yogesh Subhash Chaudhari, Manisha Yogesh Chaudhari, Abhijeet Vishnu Puri · Preprints.org · 2024
Showing 5 of 8 known citations — external sources report more than can currently be individually listed.
Related research
- Toxicity Impact on Bioaccumulation of Potentially Toxic Elements in African Giant Land Snail (Archachatina margenata) Treated with Different Soils and Its Ecological Risk Assessment — shares topic coverage
- Fire Risk Evaluation for Petroleum Products Handling Facilities in Niger Delta Region, Nigeria — shares topic coverage
- Evaluation of Workers Participation in Risk Assessment of Underwater Operations in the Oil and Gas Industry — shares topic coverage
- Quantitative Risk Assessment of Naval Vessels Operating in Niger Delta Waterways Using Fault Tree Analysis — shares topic coverage
- Implementation of QbD Principles for Simultaneous Quantitative Expression of Olmesartan Medoxomil, Telmisartan and Hydrochlorothiazide by RP-HPLC — shares topic coverage
Article metrics
Real usage data collected on this platform.
5
Page views
0
PDF downloads
0
Outbound clicks
8
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.